47 related articles for article (PubMed ID: 26998152)
1. M
Li M; Guo Q; Shi Q; Rao Y; Dong Y; Chen F; Qi X
Discov Oncol; 2023 Sep; 14(1):175. PubMed ID: 37733108
[TBL] [Abstract][Full Text] [Related]
2. The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors.
Jin Y; Chen DL; Wang F; Yang CP; Chen XX; You JQ; Huang JS; Shao Y; Zhu DQ; Ouyang YM; Luo HY; Wang ZQ; Wang FH; Li YH; Xu RH; Zhang DS
Mol Cancer; 2020 Oct; 19(1):154. PubMed ID: 33126883
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma.
Yang MH; Yen CH; Chen YF; Fang CC; Li CH; Lee KJ; Lin YH; Weng CH; Liu TT; Huang SF; Teh BT; Chen YA
Sci Rep; 2019 Feb; 9(1):2552. PubMed ID: 30796242
[TBL] [Abstract][Full Text] [Related]
4. P-Rex1 and P-Rex2 RacGEFs and cancer.
Srijakotre N; Man J; Ooms LM; Lucato CM; Ellisdon AM; Mitchell CA
Biochem Soc Trans; 2017 Aug; 45(4):963-77. PubMed ID: 28710285
[TBL] [Abstract][Full Text] [Related]
5. Replication Study: Melanoma genome sequencing reveals frequent
Horrigan SK; Courville P; Sampey D; Zhou F; Cai S;
Elife; 2017 Jan; 6():. PubMed ID: 28100394
[TBL] [Abstract][Full Text] [Related]
6. Genetic Predisposition to Hepatocellular Carcinoma.
Pascale RM; Calvisi DF; Feo F; Simile MM
Metabolites; 2022 Dec; 13(1):. PubMed ID: 36676960
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of PREX2 promotes the proliferation and migration of hepatocellular carcinoma cells via PTEN-AKT signaling.
He S; Lin J; Yu S; Sun S
Oncol Lett; 2016 Mar; 11(3):2223-2228. PubMed ID: 26998152
[TBL] [Abstract][Full Text] [Related]
8. PREX2 promotes the proliferation, invasion and migration of pancreatic cancer cells by modulating the PI3K signaling pathway.
Yang J; Gong X; Ouyang L; He W; Xiao R; Tan L
Oncol Lett; 2016 Aug; 12(2):1139-1143. PubMed ID: 27446408
[TBL] [Abstract][Full Text] [Related]
9. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.
Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z
Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130
[TBL] [Abstract][Full Text] [Related]
10. The effect of CXCL9 on the invasion ability of hepatocellular carcinoma through up-regulation of PREX2.
Lan X; Xiao F; Ding Q; Liu J; Liu J; Li J; Zhang J; Tian DA
J Mol Histol; 2014 Dec; 45(6):689-96. PubMed ID: 25151370
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the GNMT-HectH9-PREX2 tripartite relationship in the pathogenesis of hepatocellular carcinoma.
Li CH; Yen CH; Chen YF; Lee KJ; Fang CC; Zhang X; Lai CC; Huang SF; Lin HK; Arthur Chen YM
Int J Cancer; 2017 May; 140(10):2284-2297. PubMed ID: 28205209
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]